Hannestad J. In line with the present Infflammation, a Inflammation and sleep quality of individuals who were Liver detoxification benefits yearly during adolescence qualiyy age 11 slee; 16 years, and then again at 19 Invlammation Inflammation and sleep quality, reported separate positive relationships between qhality depressive Digestive Health Aid or recurrent episodes of depression at a given visit and CRP at the next visit [ 27 ]; notably, only recurrent, cumulative depressive episodes were associated with CRP after accounting for covariates in that study. Slow wave sleep SWS. CAS PubMed PubMed Central Google Scholar Cole, S. Major depressive disorder often coincides with chronic diseases such as cardiovascular disease, arthritis, and diabetes [ 23 ], many of which are leading causes of death and disability [ 4 ].

Inflammation and sleep quality -

The PSQI, for its part, has been shown to be both valid and reliable in numerous populations for example, [ 71 , 98 , 99 ] and is well suited to examine qualitative aspects of sleep in addition to sleep duration and other insomnia symptoms.

Nonetheless, we cannot exclude the possibility that poor sleepers in the current study may have been suffering from obstructive sleep apnea, although no participants had received a previous diagnosis of sleep apnea.

The prevalence of sleep apnea in the population, particularly in healthy individuals, is considerably lower [ , ] than the prevalence of poor sleepers observed in this study, suggesting that sleep apnea is unlikely to explain the current results.

Inflammatory markers in the current study were measured only once. Repeated measurements would have permitted a better validation of inflammatory activity. A small sample size and number of participants with clinical elevations in CRP are additional limitations.

On the other hand, strengths of the study include that our population was healthy no known illnesses or medications with the potential to impact on inflammatory processes, including hormone therapy and well characterized in terms of socio-demographics, psychological profile, and health behaviors, which allowed us to assess the relationship between sleep and inflammatory activity independent of potential confounding.

Recruitment and sampling of both men and women were performed in numbers sufficient to evaluate independent effects, with oversampling of women to permit examination of women in pre- vs. postmenopausal state. Multiple inflammatory markers were measured, increasing the confidence that can be had in results.

Considering the significance of the results despite exclusion of individuals with known sleep pathologies underscores the importance of sleep to inflammatory activity. In summary, poor sleep quality is associated with greater inflammation in apparently healthy individuals without a known sleep disorder, independently of sex and menopausal status.

There was only limited evidence that postmenopausal women were particularly at risk. Further investigations are required to clarify the direction of effect, and the mechanisms involved in this association.

Indeed, there is data to suggest that cytokine activity can regulate or modulate sleep-wake behavior [ ] and that increased levels through the administration of IL-6 for example can contribute to sleep difficulties and increased fatigue [ ].

Future studies should also longitudinally assess whether this relationship is involved in the development of chronic diseases in apparently healthy individuals, with a specific attention to differences as a function of sex and menopausal status.

Screening for sleep quantity and quality and providing the necessary education or treatment for disordered sleep may be an important means through which to minimize its impact on health. Matthews KA, Pantesco EJ.

Sleep characteristics and cardiovascular risk in children and adolescents: an enumerative review. Sleep medicine. Article PubMed Google Scholar.

Elwood P, Hack M, Pickering J, Hughes J, Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health. Pubmed Central PMCID: Article Google Scholar. Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study.

Spiegelhalder K, Scholtes C, Riemann D. The association between insomnia and cardiovascular diseases. Nature and science of sleep. PubMed PMID: Article PubMed PubMed Central Google Scholar. Plante GE. Sleep and vascular disorders. Article CAS PubMed Google Scholar.

Hsu C-Y, Chen Y-T, Chen M-H, Huang C-C, Chiang C-H, Huang P-H, et al. The association between insomnia and increased future cardiovascular events: a nationwide population-based study. Psychosomatic medicine.

Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al.

Short sleep duration as a risk factor for hypertension - analyses of the first national health and nutrition examination survey. Schwartz S, Anderson WM, Cole SR, Cornoni-Huntley J, Hays JC, Blazer D. Insomnia and heart disease: a review of epidemiologic studies.

J Psychosom Res. Chien KL, Chen PC, Hsu HC, Su TC, Sung FC, Chen MF, et al. Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort. Khan MK, Chu YL, Kirk SF, Veugelers PJ.

Are sleep duration and sleep quality associated with diet quality, physical activity, and body weight status? A population-based study of Canadian children. Can J Public Health. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I.

Clark AJ, Salo P, Lange T, Jennum P, Virtanen M, Pentti J, et al. Onset of impaired sleep and cardiovascular disease risk factors: a longitudinal study. Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope.

Journal of psychosomatic research. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes.

Diabetes Care. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. Miller MA, Kandala NB, Kivimaki M, Kumari M, Brunner EJ, Lowe GD, et al.

Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Mills PJ, von Kanel R, Norman D, Natarajan L, Ziegler MG, Dimsdale JE. Inflammation and sleep in healthy individuals. Mantua J, Spencer RM. The interactive effects of nocturnal sleep and daytime naps in relation to serum C-reactive protein.

Hall MH, Smagula SF, Boudreau RM, Ayonayon HN, Goldman SE, Harris TB, et al. Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: the health, aging and body composition study.

Cho HJ, Seeman TE, Kiefe CI, Lauderdale DS, Irwin MR. Sleep disturbance and longitudinal risk of inflammation: moderating influences of social integration and social isolation in the Coronary Artery Risk Development in Young Adults CARDIA study. Brain Behav Immun. Fernandez-Mendoza J, Baker JH, Vgontzas AN, Gaines J, Liao D, Bixler EO.

Insomnia symptoms with objective short sleep duration are associated with systemic inflammation in adolescents. Duchatelle V, Kritikou EA, Tardif JC. Clinical value of drugs targeting inflammation for the management of coronary artery disease.

Can J Cardiol. Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease.

Panichi V, Scatena A, Migliori M, Marchetti V, Paoletti S, Beati S. Biomarkers of chronic inflammatory state in uremia and cardiovascular disease. Int J Inflamm. Article CAS Google Scholar. Ridker PM. High-sensitivity C-reactive protein - potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.

Devaraj S, Valleggi S, Siegel D, Jialal I. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.

Curr Atheroscler Rep. Article CAS PubMed PubMed Central Google Scholar. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

New Engl J Med. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.

Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 initially healthy American women. Heeschen C, Hamm CW, Bruemmer J, Simoons ML.

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am College Cardiol. Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, et al.

Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Simpson N, Dinges DF. Sleep and inflammation. Nutr Rev. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol.

Li Q, Zheng X. Tumor necrosis factor alpha is a promising circulating biomarker for the development of obstructive sleep apnea syndrome: a meta-analysis.

PubMed PubMed Central Google Scholar. Li K, Wei P, Qin Y, Wei Y. Is C-reactive protein a marker of obstructive sleep apnea? A meta-analysis. Cacacho ALF, Carpi TM, Alonso DP, Robles ALS, Gomez VG, Marin PC, et al. Long term changes of C-rective protein CRP in obstructive sleep apnoea OSA with or without treatment.

Eur Respiratory Soc. Motamedi V, Kanefsky R, Matsangas P, Mithani S, Jeromin A, Brock MS, et al. Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea. Sleep Med. Teramoto S, Yamamoto H, Ouchi Y. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome.

Tie Y, Fu Y, Xu Z, Peng Y. Relationship between C-reactive protein levels and obstructive sleep apnea syndrome. Genet Mol Res. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity.

J Clin Endocrinol Metab. von Kanel R, Dimsdale JE, Ancoli-Israel S, Mills PJ, Patterson TL, McKibbin CL, et al. J Am Geriatr Soc. Friedman EM. Sleep quality, social well-being, gender, and inflammation: an integrative analysis in a national sample.

Ann N Y Acad Sci. Nowakowski S, Matthews KA, von Känel R, Hall MH, Thurston RC. Sleep characteristics and inflammatory biomarkers among midlife women. Article PubMed Central Google Scholar.

Meng L-L, Tang Y-Z, Ni C-L, Yang M, Song H-N, Wang G, et al. Impact of inflammatory markers on the relationship between sleep quality and incident cardiovascular events in type 2 diabetes.

J Diabetes Complicat. Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults.

Cappuccio FP, Stranges S, Kandala NB, Miller MA, Taggart FM, Kumari M, et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension - the Whitehall II study. Hypertension, Sabanayagam C, Shankar A.

Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Suarez EC. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Irwin MR, Carrillo C, Olmstead R.

Sleep loss activates cellular markers of inflammation: sex differences. Sleep duration trajectories and systemic inflammation in young adults: results from the national longitudinal study of adolescent to adult health add health.

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Campesi I, Occhioni S, Tonolo G, Cherchi S, Basili S, Carru C, et al. Int J Med Sci. Rosano GMC, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence.

Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, et al. Adipokines, Inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metabol. Routledge FS, McFetridge-Durdle JA, Dean CR.

Stress, menopausal status and nocturnal blood pressure dipping patterns among hypertensive women. Pubmed Central PMCID: PMC Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM.

Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. PubMed Google Scholar. Baker FC, Lampio L, Saaresranta T, Polo-Kantola P. Sleep and sleep disorders in the menopausal transition.

Sleep Med Clin. Mirer AG, Young T, Palta M, Benca RM, Rasmuson A, Peppard PE. Sleep-disordered breathing and the menopausal transition among participants in the Sleep in Midlife Women Study. Menopause New York, NY. Resta O, Bonfitto P, Sabato R, De Pergola G, Barbaro MP.

Prevalence of obstructive sleep apnoea in a sample of obese women: effect of menopause. Diabetes Nutr Metab. CAS PubMed Google Scholar. Ameratunga D, Goldin J, Hickey M. Sleep disturbance in menopause.

Intern Med J. Kravitz HM, Zhao X, Bromberger JT, Gold EB, Hall MH, Matthews KA, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women.

Tom SE, Kuh D, Guralnik JM, Mishra G. Self-reported sleep difficulty during the menopausal transition: results from a prospective cohort study. Vahratian A. Sleep duration and quality among women aged , by Menopausal Status: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; Xu Q, Lang CP.

Examining the relationship between subjective sleep disturbance and menopause: a systematic review and meta-analysis. Shaver JL, Zenk SN. J Womens Health Gend Based Med. Knutson KL, Phelan J, Paskow MJ, Roach A, Whiton K, Langer G, et al. Sleep health. Prinz PN, Bailey SL, Woods DL. Sleep impairments in healthy seniors: roles of stress, cortisol, and interleukin-1 beta.

Chronobiol Int. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index - a new instrument for psychiatric practice and research. Psychiatry Res. Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F.

Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. Beck ATSR, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; Google Scholar.

Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research Endorsed by the American Psychiatric Association.

Ma Y, Chiriboga DE, Pagoto SL, Rosal MC, Li W, Merriam PA, et al. Association between depression and C-reactive protein. Cardiol Res Practice. Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.

Hemodial Int. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. Eur Heart J. Ekelund U, Anderssen S, Froberg K, Sardinha LB, Andersen LB, Brage S, et al.

Independent associations of physical activity and cardiorespiratory fitness with metabolic risk factors in children: the European youth heart study. Viitasalo A, Lakka TA, Laaksonen DE, Savonen K, Lakka H-M, Hassinen M, et al.

Validation of metabolic syndrome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults. Franks PW, Ekelund U, Brage S, Wong M-Y, Wareham NJ. Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness?

Diabetes care. Ekelund U, Brage S, Froberg K, Harro M, Anderssen SA, Sardinha LB, et al. TV viewing and physical activity are independently associated with metabolic risk in children: the European Youth Heart Study. PLoS medicine. Shamsuzzaman ASM, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al.

Elevated c-reactive protein in patients with obstructive sleep apnea. Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E. Correlates of serum C-reactive protein CRP - no association with sleep duration or sleep disordered breathing.

Okun ML, Coussons-Read M, Hall M. Disturbed sleep is associated with increased C-reactive protein in young women. Laugsand LE, Asvold BO, Vatten LJ, Romundstad PR, Wiseth R, Hveem K, et al.

Metabolic factors and high-sensitivity C-reactive protein: the HUNT study. Eur J Prev Cardiol. Festa A, D'Agostino R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes. Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimäki M.

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain, Behav, Immun.

Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. Liukkonen T, Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Koponen H, Timonen M.

Gilliver SC. Sex steroids as inflammatory regulators. J Steroid Biochem Molecular Biol. Barnes PJ, Karin M. Mechanisms of disease - nuclear factor-kappa b - a pivotal transcription factor in chronic inflammatory diseases.

N Engl J Med. Irwin MR, Wang M, Ribeiro D, Cho HJ, Olmstead R, Breen EC, et al. Sleep loss activates cellular inflammatory signaling. Sowers MR, Matthews KA, Jannausch M, Randolph JF, McConnell D, Tyrrell KS, et al.

Hemostatic factors and estrogen during the menopausal transition. Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Corrado E, Rizzo M, Muratori I, Coppola G, Novo S.

Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. Prinz PN. Age impairments in sleep, metabolic and immune functions. Exp Gerontol. Littner M, Hirshkowitz M, Kramer M, Kapen S, Anderson WM, Bailey D, et al. Practice parameters for using polysomnography to evaluate insomnia: an update.

Buysse DJ, Reynolds CF 3rd, Monk TH, Hoch CC, Yeager AL, Kupfer DJ. Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index PSQI. Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A.

Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manag. Coleman RM, Roffwarg HP, Kennedy SJ, Guilleminault C, Cinque J, Cohn MA, et al. Sleep-wake disorders based on a polysomnographic diagnosis: a national cooperative study.

Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review.

Sleep Med Reviews. Opp MR. Cytokines and sleep. Sleep Med Rev. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Trakada G, Chrousos GP. IL-6 and its circadian secretion in humans. Download references. This research was supported by grants attributed to BDA from the Canadian Institutes of Health Research CIHR, MOP and and the Montreal Heart Institute Foundation.

Special thanks to the staff and students of the laboratory and participants of the study for their generous time. The funding sources played no role in the design, collection, analysis, interpretation of data, nor in the writing of the manuscript.

Research Center, Montreal Heart Institute, Belanger Street, Montreal, Quebec, H1T 1C8, Canada. Psychology Department, Université de Montréal, Montreal, Quebec, Canada.

You can also search for this author in PubMed Google Scholar. BDA designed the study, analyzed and interpreted the results, and wrote the manuscript. Established risk factors for cardiovascular disease in humans include poor diet, lack of exercise, obesity, high blood pressure and smoking.

Using statistical modeling, the researchers analyzed the diagnostic data of more than 1, middle-aged and older adults using a national dataset known as the Multi-Ethnic Study of Atherosclerosis.

To isolate the effect of sleep quality on heart health, the study controlled for age, ethnicity, gender, body mass index, sleep disorders, blood pressure and high-risk behaviors such as smoking. The researchers then tracked the results of the study participants, analyzing their blood tests, their calcium scores that can gauge plaque buildup, as well as several different measures of sleep, including wristwatch-assessed sleep across a week and a night in a sleep laboratory that measured electrical brainwave signals.

The final outcome clearly linked disrupted sleep patterns to higher concentrations of circulating inflammatory factors and, specifically, of white blood cells known as monocytes and neutrophils, which are key players in atherosclerosis, researchers said.

The findings linking poor sleep to atherosclerosis via chronic inflammation have major public health implications, researchers said. For example, atherosclerosis often begins in early adulthood.

a Department of Epidemiology and Biostatistics, School of Public Qualify, Jilin University, Changchun, P. Aims : The Inf,ammation Inflammation and sleep quality of both sleep disorders Intlammation frailty Herbal tea for digestion chronic inflammation, which can Hyperthyroidism Support reflected selep the dietary Inflamnation index Invlammation. Therefore, we aimed to explore qualitg association between sleep quality, frailty, and dietary inflammation. Methods : participants aged over 20 years from the National Health and Nutrition Examination Survey NHANES in — were involved in the study. Dietary inflammation was assessed by DII, sleep quality was assessed by the Pittsburgh sleep quality index PSQIand frailty was assessed by the item frailty index FI. Logistic regression, stratified analysis of sub-groups, and forest plots were used in this study. Results : Both pro-inflammatory diet and poor sleep quality were risk factors for frailty. Inflammationn, insufficient Inflammqtion can negatively affect immune cells, Inflammation and sleep quality may lead to inflammatory disorders and cardiovascular disease, according to a Inflammation and sleep quality study from qualityy Icahn School of Medicine at Mount Sinai. Inflammatuon specifically, consistently losing Infpammation hour and a half of sleep a night potentially increases Energy metabolism and autoimmune diseases risk. Inflsmmation research, published Inflammarion 21 in the Journal High-protein snacks Experimental Medicineis the first to show that sleep alters the structure of DNA inside the immune stem cells that produce white blood cells—also known as immune cells—and this can have a long-lasting impact on inflammation and contribute to inflammatory diseases. Immune cells fight infection, but if the number of these cells gets too high, they overreact and cause inflammation. It shows that in humans and mice, disrupted sleep has a profound influence on the programming of immune cells and rate of their production, causing them to lose their protective effects and actually make infections worse—and these changes are long-lasting. A team of investigators analyzed 14 healthy adults who regularly sleep eight hours a night.

Video

How to Improve Your Sleep Quality